FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added brain tumor warning to the label.

The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused their meningiomas.

See more stories on Insider's business page. A third dose of Pfizer's coronavirus vaccine yields mild to moderate side effects, much like the second shot, according to data released this month by the ...

(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...

If Nebraska obtained drugs made by Pfizer, it risks a lawsuit from the company or one of its distributors claiming that it violated the company’s ban on using drugs on its list of “restricted products ...

YaoPharma's pill targets the GLP-1 hormone, the same mechanism behind Novo Nordisk's widely used Wegovy injection, but remains in early clinical development. YaoPharma will run an initial trial, after ...